The
following securities are excluded from the calculation of weighted average dilutive common shares because their inclusion would have
been anti-dilutive:
SCHEDULE
OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE
|
|
2023 |
|
|
2022 |
|
|
|
As
of March 31, |
|
|
|
2023 |
|
|
2022 |
|
|
|
|
|
|
|
|
Options |
|
|
34,806 |
|
|
|
561,027 |
|
Warrants |
|
|
4,839,254 |
|
|
|
2,024,166 |
|
Unvested restricted stock
units |
|
|
517,610 |
|
|
|
- |
|
Convertible
debt |
|
|
5,827,783
|
[1] |
|
|
1,897,860 |
[2]
|
Total
potentially dilutive shares |
|
|
11,219,453 |
|
|
|
4,483,053 |
|
[1] |
|
Represents shares
issuable upon conversion of $5,536,394 in convertible debt outstanding as of March 31, 2023 at a conversion price of $0.95 per share,
which represents the conversion price in effect as of March 31, 2023. The conversion price of such debt is variable (see Note 9, Convertible Debt Obligations). |
[2] |
|
Represents shares
issuable upon conversion of principal and interest outstanding in the aggregate amount of $6,642,510 at a conversion price of $3.50 per
share. |
|